
Precision for Medicine
Discovery, development, clinical trial work, and implementation of biomarkers essential for targeting patients more precisely and effectively.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor investor investor | €0.0 | round | |
$75.0m | Growth Equity VC | ||
Total Funding | 000k |
Related Content
Precision For Medicine is a global clinical research organization (CRO) that specializes in integrating advanced technologies to maximize insights into patient biology. The company serves life sciences clients, including pharmaceutical and biotechnology companies, by supporting clinical trials at every stage from first-in-human to regulatory approval. Precision For Medicine operates in the precision medicine market, focusing on oncology, cell and gene therapy, and rare and orphan diseases. The business model revolves around offering comprehensive clinical trial services, specialty lab services, and data sciences to enhance the speed, cost-efficiency, and success rate of bringing life-changing therapies to patients. Revenue is generated through contracts with life sciences companies for conducting clinical trials, providing biostatistical support, and offering specialized laboratory services.
Keywords: clinical trials, precision medicine, oncology, cell therapy, gene therapy, rare diseases, biostatistics, specialty labs, data sciences, regulatory approval.
Tech stack
Investments by Precision for Medicine
Edit


